Table 1. Demographic and perioperative characteristics.
| Parameters | Propofol (n = 20) | Desflurane (n = 20) |
|---|---|---|
| Age (yr) | 50.00 ± 11.83 | 50.45 ± 9.37 |
| Weight (kg) | 55.80 ± 5.98 | 59.90 ± 7.91 |
| Height (cm) | 157.90 ± 5.37 | 158.40 ± 6.10 |
| ASA physical status (I/II/III) | 12/8/0 | 14/6/0 |
| Crystalloid infusion (mL) | 765.00 ± 188.56 | 785.00 ± 219.51 |
| Blood loss (mL) | 35.00 ± 26.46 | 44.50 ± 25.23 |
| Duration of anesthesia (min) | 178.00 ± 43.66 | 201.25 ± 54.14 |
| Duration of surgery (min) | 137.50 ± 42.04 | 164.00 ± 50.90 |
| Diagnosis | ||
| Intraductal carcinoma | 16 | 19 |
| Intraductal papilloma | 2 | 0 |
| DCIS | 2 | 1 |
| Stage (0/I/II/III)* | 0/13/6/1 | 1/10/6/2 |
| Operation | ||
| Mastectomy with axillary node clearance | 1 | 4 |
| Breast conserving surgery with sentinel node biopsy | 19 | 16 |
| Intraoperative fentanyl consumption (µg) | 175 ± 61 | 145 ± 42 |
| Pain score, 12 hr postoperatively | 1.90 ± 0.72 | 1.55 ± 0.10 |
| Pain score, 24 hr postoperatively | 0.25 ± 0.55 | 0.05 ± 0.22 |
*Stage by American Joint Committee on cancer staging system. ASA, American Society of Anesthesiologists; DCIS, ductal carcinoma in situ.